Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a smart pump make Post-Surgical pain relief safer?

NCT ID NCT04011163

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 07, 2026 · Last updated Aug 07, 2026

Summary

This trial is testing a new smart pump (VPIA) that delivers morphine for pain after surgery while continuously monitoring breathing. The goal is to see if this system can provide effective pain relief while reducing the risk of breathing problems. The study involves adults aged 21-70 who need morphine for post-operative pain. The pump uses advanced software to adjust pain medication based on vital signs, aiming to improve patient satisfaction and safety.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A smart infusion pump (VPIA) that delivers intravenous morphine and monitors vital signs to adjust pain relief.
What this could lead to
If successful, this could lead to a safer, more personalized way to manage post-surgical pain, reducing the risk of breathing problems while improving patient comfort.
What could go wrong
This is an early-stage trial with a small number of participants, so the results may not apply to everyone. The technology might not work as intended or could have unexpected side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2/3

Runs two stages together: whether the treatment works, then large-scale confirmation.

Participants

40 people

The number who actually took part.

Started

Mar 2021

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 70 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * American Society of Anaesthesiologist (ASA) physical status I-III; * Age 21-70 years; * Receiving patient controlled analgesia of morphine for postoperative analgesia. Exclusion Criteria: * Allergy to study drug; * With significant respiratory disease and obstructive sleep apnea; * Unwilling to place oxygen saturation and respiratory rate monitoring during study period; * Unable to comprehend the use of patient controlled analgesia; * Obstetric patients.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Hypoventilation Pain Pain, Postoperative respiratory failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • KK Women's and Children's Hospital

    Singapore, 229899, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.